The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer

Despite modern advances in cancer medicine, pancreatic cancer survival remains unchanged at just 12%. For the small proportion of patients diagnosed with ‘early’ (upfront or borderline resectable) disease, recurrences are common, and many recur soon after surgery. Whilst chemotherapy has been shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Maloney, Sarah, Clarke, Stephen J., Sahni, Sumit, Hudson, Amanda, Colvin, Emily, Mittal, Anubhav, Samra, Jaswinder, Pavlakis, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587199/
https://www.ncbi.nlm.nih.gov/pubmed/37460806
http://dx.doi.org/10.1007/s00432-023-05149-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587199/
https://www.ncbi.nlm.nih.gov/pubmed/37460806
http://dx.doi.org/10.1007/s00432-023-05149-4

Ejemplares similares